GlycoMira
1 follower
GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.
Org chart
William P. Tew
CEO & Chairman
Collapse
Thomas P. Kennedy
Co-Founder, CMO & Director
Justin R. Savage
SVP of Operations
Tom Heath
President And CFO
Ken North
Chief Financial Officer
Board & advisors
Stephen T. Sonis
Advisor